Safety profile for the clinical use of bone morphogenetic proteins in the spine.
about
BMPs and their clinical potentialsBRITER: a BMP responsive osteoblast reporter cell lineUse of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesisLessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?Trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory?A meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graftDelivery of bioactive lipids from composite microgel-microsphere injectable scaffolds enhances stem cell recruitment and skeletal repair.Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2)Delivery of bone morphogenetic protein-2 and substance P using graphene oxide for bone regenerationAccelerated postero-lateral spinal fusion by collagen scaffolds modified with engineered collagen-binding human bone morphogenetic protein-2 in ratsAnabolic therapies.Three-dimensionally presented anti-fouling zwitterionic motifs sequester and enable high-efficiency delivery of therapeutic proteins.Bone morphogenetic protein-2-impregnated biomimetic scaffolds successfully induce bone healing in a marginal mandibular defectElectrical stimulation therapies for spinal fusions: current concepts.Nell-1 protein promotes bone formation in a sheep spinal fusion model.Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats.Application of AMOR in craniofacial rabbit bone bioengineering.Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrierClinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 casesStudies of bone morphogenetic protein-based surgical repair.Point-counter-point debate: the association between recombinant human bone morphogenetic protein utilization and complications in spine surgery.BMP-2 and BMP-2/7 Heterodimers Conjugated to a Fibrin/Hyaluronic Acid Hydrogel in a Large Animal Model of Mild Intervertebral Disc Degeneration.Growth factor delivery for bone tissue repair: an update.Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.The use of rhBMP in spine surgery: is there a cancer risk?Safety and efficacy of use of demineralised bone matrix in orthopaedic and trauma surgery.Union Rate and Complications in Spine Fusion with Recombinant Human Bone Morphogenetic Protein-7: Systematic Review and Meta-Analysis.Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein.Enhanced Bone Repair by Guided Osteoblast Recruitment Using Topographically Defined Implant.RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer CellsVertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep ModelAntagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callusEvidence supporting the use of bone morphogenetic proteins for spinal fusion surgery.Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report.rhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo.In vivo and in vitro investigations of a nanostructured coating material - a preclinical study.The use of recombinant human BMP-2 as a salvage procedure in the pediatric spine: a report on 3 cases.Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases.Acute Intravenous Injection Toxicity Study of Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in RatThe role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration.
P2860
Q26824827-FD83DEF0-76EF-45E6-B101-815C751EEE15Q28483777-3396DBD0-2635-4F4D-BD51-D25AEEB66D9FQ28564040-652FB345-30FF-4B06-B5A4-D3AEFD0945B5Q28606705-FB4A53B6-EC66-4550-9640-4BAE3E657B46Q28656442-449824A7-7310-488E-96ED-8B2869CC9FB6Q28658928-7B8E87FE-EC7F-48B8-8F45-052B85B4D3FFQ30411433-08E601CD-6C60-401C-8B00-C3D5AA916907Q33553896-425D3624-9968-4EC9-B35D-DECAEBAB9D1FQ33627678-177FD93F-86B1-4825-ADAF-E5D276F247BAQ33679554-937E0720-8793-4D6B-BB08-3DA443CA130CQ33737504-B86BB18A-2FD8-4090-A88F-41318FCA2A19Q34161008-C9F6C0FC-2731-471A-A9A7-2089DE78911AQ34205824-2D864672-5794-4945-9E1C-9D3F313E30B5Q34512256-D29FE84A-B50D-4F9B-BFB8-A3B2CC56947AQ34715389-D4D53F94-B50C-482A-BD49-E9BCD45AAB39Q34973974-957B9D9D-7B24-4EEB-A7B8-2CB1CDB324E7Q35075242-51B86F7D-2228-469A-91F3-F4CA123F063BQ36024538-38749C09-7AEA-4208-9289-030FA9F20B5FQ36039746-E43A5E76-D0B6-468B-BBDA-D82F9293CCAFQ36106613-D059FFB4-9370-40AB-A4E4-76E41F7468BEQ36130232-31C4A1EE-4EE7-46ED-AE4F-B000D6AC13ECQ36218049-499E5032-E647-4B51-81ED-228E9C4CC2AAQ36316612-666977C3-D216-43CF-9370-C3611381C363Q36384446-3D4C0A9B-1D1A-4DFE-A631-DADA6D68F456Q36451255-65AE1BD1-9BEC-45F5-BD04-FBDC8BCEB821Q36624999-15A37870-EF98-4DDB-838D-BA5B3A82813BQ36631818-6378EFCE-DFEE-435C-A9C3-17A060C18395Q36801669-86E70A2A-02FB-452F-A836-4D246BD928BAQ36825415-38F7D3C2-2CB6-404A-A913-38B60BC596B0Q36941559-85EAD11F-A11E-47FF-A892-4B1A02C8B73FQ37020010-6CD1704E-E45D-44D7-A0E3-D08FA87B5F7BQ37034753-D592CC16-CC29-4F7E-AEB8-850635A12166Q37038934-47864DF7-1B70-4239-A5D4-3AF14EE4F0AEQ37411094-B786D54A-9022-469A-889F-26D86803D4F3Q37492007-CABAC4A8-DC00-40C4-8C43-DA8A53246145Q37597527-0588C948-011B-4D73-8E0F-DF582DE26093Q37624440-C259D1AC-35A2-427F-AE4F-54F5028F2CE3Q37687413-A652DCB5-9EE9-4330-A1E2-D375EB1EB200Q37717865-E70FD8A7-96C7-4D7E-85C7-36F644F49DF0Q37774494-51850B57-62DD-468D-96B7-9BF9A875A5F3
P2860
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@ast
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@en
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@nl
type
label
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@ast
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@en
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@nl
prefLabel
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@ast
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@en
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@nl
P1433
P1476
Safety profile for the clinical use of bone morphogenetic proteins in the spine.
@en
P2093
Ashley R Poynton
Joseph M Lane
P356
10.1097/00007632-200208151-00010
P407
P433
16 Suppl 1
P577
2002-08-01T00:00:00Z